DOV Pharmaceutical adds global reach, cuts costs, lowers risks with advanced clinical trial management system.
A clinical trial management solution from IBM and Winchester Business Systems improves collaboration, communication among researchers and managers. Let’s say your company is a growing U.S. biopharmaceutical and has potential drug therapies in development that may have strong applicability in overseas markets. Suddenly you’re looking at managing clinical trials with patients, doctors and researchers at 50 different sites across the globe, in places like India, Israel and Guatemala, as well as in the United States. A domestic clinical trial by itself (without global sites), is a complex and delicate process—keeping track of a host of activities and milestones, keeping them on time and in compliance with the stringent oversight of the U.S. Food and Drug Administration. A report by the Tufts Center for the Study of Drug Development has cited clinical trials as the main contributor to the upward cost spiral in bringing a new prescription drug to market in the United States. The cost to bring a new drug to market now averages more than $880 million and extends over 10 to 15 years. You’ve managed previous clinical trials using basic IT support and paper-based documentation: spreadsheets, conventional e-mail, faxes, overnight mail and the like. Now, the global coordination will be vastly more complicated, and any misstep could have costly consequences in delaying FDA approval. Decisive wins That was the challenge facing DOV Pharmaceutical, Inc., of Hackensack, New Jersey in late 2004. DOV chose Protocol Manager™, a clinical trial management solution (CTMS) from IBM and Winchester Business Systems, Inc., an IBM Business Partner specializing in the healthcare and life sciences industry. Winchester, which was founded in 1989, is headquartered in Woburn, Massachusetts. Meeting the challenge demonstrated how IBM and Winchester brought exactly the right focus to a customer problem and also led to marketplace wins for IBM and Winchester. For the complete story click either link below.